New drug trial aims to tame debilitating autoimmune disease

NCT ID NCT05349214

Summary

This large, late-stage study is testing whether a new drug called ianalumab can help control the disease and reduce symptoms for people with active Sjogren's syndrome. About 500 participants will receive injections of either the drug or a placebo for nearly a year to see if it safely lowers disease activity and improves dryness, pain, and fatigue. The goal is to see if this treatment can provide better long-term management of this chronic autoimmune condition.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SJOGREN SYNDROME are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Advanced Medical Research

    La Palma, California, 90623, United States

  • Advanced Rheumatology of Houston

    Spring, Texas, 77382, United States

  • Arthritis Northwest PLLC

    Spokane, Washington, 99204, United States

  • Arthritis Osteoporosis Assoc of NM

    Las Cruces, New Mexico, 88011, United States

  • Arthritis and Osteoporosis

    Charlotte, North Carolina, 28207, United States

  • Augusta University Georgia

    Augusta, Georgia, 30912, United States

  • Bay Area Arthritis And Osteoporosis

    Brandon, Florida, 33511, United States

  • Clin Invest Specialists Inc

    Orland Park, Illinois, 60467, United States

  • Clinic of Robert Hozman

    Skokie, Illinois, 60176, United States

  • Clinical Investigation Specialists, Inc.

    Wauconda, Illinois, 60084, United States

  • First Outpatient Research Unit

    San Antonio, Texas, 78229, United States

  • GNP Research

    Cooper City, Florida, 33024, United States

  • North Georgia Rheumatology Group

    Lawrenceville, Georgia, 30046, United States

  • Novartis Investigative Site

    CABA, Buenos Aires, C1405BCH, Argentina

  • Novartis Investigative Site

    Quilmes, Buenos Aires, 1878, Argentina

  • Novartis Investigative Site

    San Miguel Tucuman, Tucumán Province, T4000DPK, Argentina

  • Novartis Investigative Site

    Buenos Aires, 1646, Argentina

  • Novartis Investigative Site

    Buenos Aires, C1055AAF, Argentina

  • Novartis Investigative Site

    Buenos Aires, C1428DQG, Argentina

  • Novartis Investigative Site

    Maroochydore, Queensland, 4558, Australia

  • Novartis Investigative Site

    Woodville South, South Australia, 5011, Australia

  • Novartis Investigative Site

    Hobart, Tasmania, 7000, Australia

  • Novartis Investigative Site

    Salvador, Estado de Bahia, 40150 150, Brazil

  • Novartis Investigative Site

    Curitiba, Paraná, 80030-110, Brazil

  • Novartis Investigative Site

    São Paulo, São Paulo, 04266 010, Brazil

  • Novartis Investigative Site

    Burgas, 8000, Bulgaria

  • Novartis Investigative Site

    Plovdiv, 4002, Bulgaria

  • Novartis Investigative Site

    Sofia, 1606, Bulgaria

  • Novartis Investigative Site

    Vancouver, British Columbia, V5Z 1L7, Canada

  • Novartis Investigative Site

    Sydney, Nova Scotia, B1P 1P3, Canada

  • Novartis Investigative Site

    Toronto, Ontario, M5T 2S8, Canada

  • Novartis Investigative Site

    Rimouski, Quebec, G5L 5T1, Canada

  • Novartis Investigative Site

    Sherbrooke, Quebec, J1G 2E8, Canada

  • Novartis Investigative Site

    Trois-Rivières, Quebec, G9A 3Y2, Canada

  • Novartis Investigative Site

    Concepción, Bio Bio, 4070280, Chile

  • Novartis Investigative Site

    Valdivia, Los Ríos Region, 5110683, Chile

  • Novartis Investigative Site

    Santiago, RM, 7500588, Chile

  • Novartis Investigative Site

    Hefei, Anhui, 230001, China

  • Novartis Investigative Site

    Chongqing, Chongqing Municipality, 400010, China

  • Novartis Investigative Site

    Nanjing, Jiangsu, 210008, China

  • Novartis Investigative Site

    Nanchang, Jiangxi, 330006, China

  • Novartis Investigative Site

    Pingxiang, Jiangxi, 337000, China

  • Novartis Investigative Site

    Changchun, Jilin, 130021, China

  • Novartis Investigative Site

    Taiyuan, Shanxi, 030001, China

  • Novartis Investigative Site

    Chengdu, Sichuan, 610041, China

  • Novartis Investigative Site

    Yinchuan, The Ningxia Hui Autonomous Reg, 750000, China

  • Novartis Investigative Site

    Ürümqi, Xinjiang, 830001, China

  • Novartis Investigative Site

    Hangzhou, Zhejiang, 310006, China

  • Novartis Investigative Site

    Beijing, 100029, China

  • Novartis Investigative Site

    Beijing, 100730, China

  • Novartis Investigative Site

    Shanghai, 200011, China

  • Novartis Investigative Site

    Shanghai, 200040, China

  • Novartis Investigative Site

    Tianjin, 300052, China

  • Novartis Investigative Site

    Xinxiang, 453099, China

  • Novartis Investigative Site

    Medellín, Antioquia, 050001, Colombia

  • Novartis Investigative Site

    Barranquilla, Atlántico, 080002, Colombia

  • Novartis Investigative Site

    Bogota, Cundinamarca, 110221, Colombia

  • Novartis Investigative Site

    Bucaramanga, Santander Department, 680003, Colombia

  • Novartis Investigative Site

    Angers, 49933, France

  • Novartis Investigative Site

    Brest, 29200, France

  • Novartis Investigative Site

    Le Kremlin-Bicêtre, 94275, France

  • Novartis Investigative Site

    Le Mans, 72000, France

  • Novartis Investigative Site

    Strasbourg, 67000, France

  • Novartis Investigative Site

    Cologne, North Rhine-Westphalia, 50937, Germany

  • Novartis Investigative Site

    Dresden, Saxony, 01307, Germany

  • Novartis Investigative Site

    Berlin, 13125, Germany

  • Novartis Investigative Site

    Hanover, 30625, Germany

  • Novartis Investigative Site

    Herne, 44649, Germany

  • Novartis Investigative Site

    Athens, 115 21, Greece

  • Novartis Investigative Site

    Athens, 115 27, Greece

  • Novartis Investigative Site

    Székesfehérvár, Fejér, 8000, Hungary

  • Novartis Investigative Site

    Debrecen, Hajdu Bihar Megye, 4032, Hungary

  • Novartis Investigative Site

    Eger, 3300, Hungary

  • Novartis Investigative Site

    Gyula, 5700, Hungary

  • Novartis Investigative Site

    Szeged, 6725, Hungary

  • Novartis Investigative Site

    Ahmedabad, Gujarat, 380013, India

  • Novartis Investigative Site

    Ahmedabad, Gujarat, 380015, India

  • Novartis Investigative Site

    Bangalore, Karnataka, 560 002, India

  • Novartis Investigative Site

    Pune, Maharashtra, 411001, India

  • Novartis Investigative Site

    New Delhi, 110029, India

  • Novartis Investigative Site

    Kfar Saba, 4428164, Israel

  • Novartis Investigative Site

    Ramat Gan, 5265601, Israel

  • Novartis Investigative Site

    Ancona, AN, 60126, Italy

  • Novartis Investigative Site

    Milan, MI, 20100, Italy

  • Novartis Investigative Site

    Salerno, SA, 84131, Italy

  • Novartis Investigative Site

    Udine, UD, 33100, Italy

  • Novartis Investigative Site

    Naples, 80131, Italy

  • Novartis Investigative Site

    Nagoya, Aichi-ken, 455-8530, Japan

  • Novartis Investigative Site

    Nagoya, Aichi-ken, 4578510, Japan

  • Novartis Investigative Site

    Nagoya, Aichi-ken, 4578511, Japan

  • Novartis Investigative Site

    Kitakyushu, Fukuoka, 8078556, Japan

  • Novartis Investigative Site

    Sapporo, Hokkaido, 0608543, Japan

  • Novartis Investigative Site

    Sapporo, Hokkaido, 0608648, Japan

  • Novartis Investigative Site

    Yokohama, Kanagawa, 2458575, Japan

  • Novartis Investigative Site

    Kuwana, Mie-ken, 511-0061, Japan

  • Novartis Investigative Site

    Sasebo, Nagasaki, 857-1195, Japan

  • Novartis Investigative Site

    Kurashiki, Okayama-ken, 7100824, Japan

  • Novartis Investigative Site

    Bunkyo Ku, Tokyo, 1138431, Japan

  • Novartis Investigative Site

    Chuo Ku, Tokyo, 1048560, Japan

  • Novartis Investigative Site

    Itabashi-ku, Tokyo, 1738610, Japan

  • Novartis Investigative Site

    Meguro-ku, Tokyo, 152-8902, Japan

  • Novartis Investigative Site

    Shinjuku-ku, Tokyo, 1608582, Japan

  • Novartis Investigative Site

    Culiacán, Sinaloa, 80000, Mexico

  • Novartis Investigative Site

    Mérida, Yucatán, 97070, Mexico

  • Novartis Investigative Site

    México, 07029, Mexico

  • Novartis Investigative Site

    Poznan, Greater Poland Voivodeship, 61-397, Poland

  • Novartis Investigative Site

    Krakow, Lesser Poland Voivodeship, 30-727, Poland

  • Novartis Investigative Site

    Wroclaw, Lower Silesian Voivodeship, 52-416, Poland

  • Novartis Investigative Site

    Warsaw, 00-874, Poland

  • Novartis Investigative Site

    Wroclaw, 50367, Poland

  • Novartis Investigative Site

    Cluj-Napoca, Cluj, 400006, Romania

  • Novartis Investigative Site

    Brasov, 500283, Romania

  • Novartis Investigative Site

    Bucharest, 010825, Romania

  • Novartis Investigative Site

    Bucharest, 011172, Romania

  • Novartis Investigative Site

    Bratislava, 811 08, Slovakia

  • Novartis Investigative Site

    Košice, 040 11, Slovakia

  • Novartis Investigative Site

    Partizánske, 958 01, Slovakia

  • Novartis Investigative Site

    Zvolen, 960 01, Slovakia

  • Novartis Investigative Site

    Panorama, Western Cape, 7500, South Africa

  • Novartis Investigative Site

    Stellenbosch, Western Cape, 7600, South Africa

  • Novartis Investigative Site

    Santander, Cantabria, 39008, Spain

  • Novartis Investigative Site

    Vigo, Pontevedra, 36214, Spain

  • Novartis Investigative Site

    Barcelona, 08041, Spain

  • Novartis Investigative Site

    Córdoba, 14004, Spain

  • Novartis Investigative Site

    Madrid, 28009, Spain

  • Novartis Investigative Site

    Valencia, 46026, Spain

  • Novartis Investigative Site

    Stockholm, SE, 113 65, Sweden

  • Novartis Investigative Site

    Kaohsiung City, 81346, Taiwan

  • Novartis Investigative Site

    Kaohsiung City, 83301, Taiwan

  • Novartis Investigative Site

    Taichung, 40447, Taiwan

  • Novartis Investigative Site

    Taichung, 407219, Taiwan

  • Novartis Investigative Site

    Doncaster, DN2 5LT, United Kingdom

  • Novartis Investigative Site

    Leeds, LS1 3EX, United Kingdom

  • Novartis Investigative Site

    Liverpool, L9 7AL, United Kingdom

  • Novartis Investigative Site

    Newcastle upon Tyne, NE1 4LP, United Kingdom

  • Novartis Investigative Site

    Swindon, SN3 6BB, United Kingdom

  • On Site Clinical Solutions Llc

    Charlotte, North Carolina, 28202, United States

  • Prolato Clinical Research Center

    Houston, Texas, 77054, United States

  • Providence Medical Foundation

    Fullerton, California, 92835, United States

  • RAO Research LLC

    Oklahoma City, Oklahoma, 73116, United States

  • Ramesh C Gupta MD Memphis TN

    Memphis, Tennessee, 38119, United States

  • Sarasota Arthritis Res Ctr

    Sarasota, Florida, 34239, United States

  • St Lawrence Health System

    Potsdam, New York, 13676, United States

  • Tufts School of Dental Medicine

    Boston, Massachusetts, 02111, United States

  • University of Kansas Hospital

    Kansas City, Kansas, 66160, United States

  • West Tennessee Research Institute

    Jackson, Tennessee, 38305, United States

Conditions

Explore the condition pages connected to this study.